Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Dawson

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
The Journal of Allergy and Clinical Immunology|January 17, 2017
Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adultsStacie M Jones, Scott H Sicherer, A Wesley Burks, et al.
Blood|July 13, 2018
Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficienciesCarl E Allen, Rebecca Marsh, Peter Dawson, et al.
Transplantation and Cellular Therapy|April 7, 2022
Impact of Center Experience with Donor Type on Outcomes: A Secondary Analysis, Blood and Marrow Transplant Clinical Trials Network 1101Open for Accrual June 2012Open for Accrual June 2012Claudio G Brunstein, Paul V O'Donnell, Brent Logan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 4, 2018
Phenotypic Characterization of Eosinophilic Esophagitis in a Large Multicenter Patient Population from the Consortium for Food Allergy ResearchMirna Chehade, Stacie M Jones, Robbie D Pesek, et al.
Plos Computational Biology|April 22, 2026
Ensemble forecasts of COVID-19 activity to support Australia's pandemic response: 2020-22Robert Moss, Ruarai J Tobin, Mitchell O'Hara-Wild, et al.
The Journal of Infectious Diseases|May 23, 2018
Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against EbolaMuhammad-Abbas Conteh, Susan T Goldstein, Haja R Wurie, et al.
Blood|November 19, 2019
Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trialJoseph Pidala, Mehdi Hamadani, Peter Dawson, et al.
Genes and Immunity|June 16, 2018
Genetic variants at the 16p13 locus confer risk for eosinophilic esophagitisLeah C Kottyan, Avery Maddox, Julian R Braxton, et al.
The Lancet. HIV|February 10, 2020
Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trialPunnee Pitisuttithum, Sorachai Nitayaphan, Suwat Chariyalertsak, et al.
The Journal of Infectious Diseases|May 23, 2018
Monitoring Serious Adverse Events in the Sierra Leone Trial to Introduce a Vaccine Against EbolaOlamide D Jarrett, Jane F Seward, Augustin E Fombah, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
The Journal of Allergy and Clinical Immunology|January 17, 2017
Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adultsStacie M Jones, Scott H Sicherer, A Wesley Burks, et al.
Blood|July 13, 2018
Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficienciesCarl E Allen, Rebecca Marsh, Peter Dawson, et al.
Transplantation and Cellular Therapy|April 7, 2022
Impact of Center Experience with Donor Type on Outcomes: A Secondary Analysis, Blood and Marrow Transplant Clinical Trials Network 1101Open for Accrual June 2012Open for Accrual June 2012Claudio G Brunstein, Paul V O'Donnell, Brent Logan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 4, 2018
Phenotypic Characterization of Eosinophilic Esophagitis in a Large Multicenter Patient Population from the Consortium for Food Allergy ResearchMirna Chehade, Stacie M Jones, Robbie D Pesek, et al.
Plos Computational Biology|April 22, 2026
Ensemble forecasts of COVID-19 activity to support Australia's pandemic response: 2020-22Robert Moss, Ruarai J Tobin, Mitchell O'Hara-Wild, et al.
The Journal of Infectious Diseases|May 23, 2018
Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against EbolaMuhammad-Abbas Conteh, Susan T Goldstein, Haja R Wurie, et al.
Blood|November 19, 2019
Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trialJoseph Pidala, Mehdi Hamadani, Peter Dawson, et al.
Genes and Immunity|June 16, 2018
Genetic variants at the 16p13 locus confer risk for eosinophilic esophagitisLeah C Kottyan, Avery Maddox, Julian R Braxton, et al.
The Lancet. HIV|February 10, 2020
Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trialPunnee Pitisuttithum, Sorachai Nitayaphan, Suwat Chariyalertsak, et al.
The Journal of Infectious Diseases|May 23, 2018
Monitoring Serious Adverse Events in the Sierra Leone Trial to Introduce a Vaccine Against EbolaOlamide D Jarrett, Jane F Seward, Augustin E Fombah, et al.
Pageof 10